Merck is playing defense against Summit Therapeutics with a $3.3 billion licensing deal announced Thursday for a cancer drug.

The Ulman Foundation, a longstanding staple in the community, recently held a ribbon-cutting for its new brick "Legacy ...

Pretty much all the movies you can catch in Twin Cities theaters this week.